Abstract
This article argues in general support of the sIRB rule, but also draws on recent empirical research to highlight several residual weaknesses in the US regulatory structure for research ethics review, and suggests ways in which these weaknesses might be addressed in future regulatory reforms to improve upon the sIRB rule.
Publisher
Cambridge University Press (CUP)
Subject
Health Policy,General Medicine,Issues, ethics and legal aspects
Reference72 articles.
1. “Rationalizing Risk Assessment in Human Subject Research,”;Coleman;Arizona Law Review,2004
2. 53. Id.
3. 55. Id. at 7209.
4. Expert perspectives on ethics review of international data-intensive research: Working towards mutual recognition
5. 21. Id. at 7150.
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献